FUDA Cancer Hospital, located in Guangzhou, Guangdong province, consisted of two regions including one in Tianhe District(located in the 2nd, Tangde Xi Road, Tianhe District, Guangzhou) and one in Haizhu District (located in Jude Zhong Road, Haizhu District, Guangzhou). Both regions are well-equiped cancer treatment centers that are well-known for their minimally invasive therapies, innovative treatments and conventional methods of chemotherapy, radiotherapy, and surgery. In 2010, Fuda Cancer Hospital became one of the National Key Clinical Cancer Speciality Centres designated by the Chinese Government. The hospital has so far received more than 15 millions RMB (estimated 2.5 million in US$) of cancer research grant.
The hospital president is Professor Xu Kecheng, a renowned and highly respected specialist of general oncology and gastroenterology. The honorary president is Professor Wu Mengchao, who is Academician of the Chinese Academy of Sciences. The hospital chief advisor is Professor Wang Zhenyi, who is another Academician serving for Fuda Cancer Hospital. The hospital has been focusing on early diagnosis and treatment of variuos cancers in the organs of pancreas, liver, lung, breast, uterus, stomach, esophagus, tongue, prostate, skin and larynx, as well as nasopharyngeal cancer, colorectal cancer and lymphoma. The hospital continually strives to provide a high quality and seamless medical services to all patients around the world.
In addition to conventional methods of chemotherapy, radiotherapy, and surgery, Fuda Cancer Hospital has been innovative in applying its unique "3C + P" cancer treatment approach, i.e. Cryosurgical Ablation (CSA), Cancer Microvessel Intervention (CMI), Combined Immunotherapy for cancer (CIC), and Personalized therapy.as well as other new technologies such as Nano knife, seed knife branchytherapy, radiofrequency ablation, photodynamic therapy, and bioimmunotherapy. So far, Fuda Cancer Hospital has performed more than 7,000 cases of cryoablations, the most number of cryablation cases in one hospital around the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda Cancer Hospital for its achievement and the International Society of Cryosurgery has designated the hospital as an international training center of cryosurgery for doctors from the Asian-Pacific region and other parts of the world. Fuda Cancer Hospital has gained a great reputation from many countries around the world, including all Southeast Asian countries, the United States, the United Kingdom, Spain, Denmark, Netherlands, Russia, etc. for its excellent medical service quality. Fuda Cancer Hospital's mission is to benefit patients with its innovative cancer therapies, and to show that the best cancer care in the world has no borders.
Professor Zhong Nanshan, president of the Chinese Medical Association, had prefaced for Tumor Cryosurgery by Professor Xu Kecheng and Dr. Niu Lizhi, saying it was the first work on tumor cryosurgery in China and speaking highly of the achievement of Fuda in cancer treatment. Academician Wang Zhenyi, a tumor specialist in hematology, and the winner of National Science and Technology Progress Award and, said CIC was a gift from God. Wu Mengchao, a specialist in surgical hepatology, and also a winner of National Science and Technology Progress Award, praised Fuda Cancer Hospitalas as well.
Fuda Cancer Hospital's achievements have been widely reported by press and TV stations around the world, including Associated Press (AP), Reuters, BBC, various newspapers of Malaysia, Indonesia, the Philippines, Canada, New Zealand and Denmark, China Central TV station (CCTV), the Health News, and the People's Daily. Fuda Cancer Hospital's achievements and successful stories of the patient are praised by people around the world.
